Black Rock Inc. Haemonetics Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,959,113 shares of HAE stock, worth $371 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,959,113
Previous 5,984,381
0.42%
Holding current value
$371 Million
Previous $511 Million
3.48%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding HAE
# of Institutions
338Shares Held
55.1MCall Options Held
665KPut Options Held
268K-
Vanguard Group Inc Valley Forge, PA5.18MShares$323 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$275 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$264 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$245 Million0.06% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.85MShares$178 Million0.14% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.2B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...